Buy Alembic Pharmaceuticals Target 930

Buy Alembic Pharmaceuticals Target 930 two Month.

Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Large Cap company (having a market cap of Rs 13111.28 Cr.) operating in Pharmaceuticals and health care sector.

Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Tablets & Capsules which contributed Rs 1202.25 Cr to Sales Value (59.10% of Total Sales), Bulk Drugs Intermediates And Chemicals which contributed Rs 360.65 Cr to Sales Value (17.73% of Total Sales), Oral Preparations & Ointments which contributed Rs 350.35 Cr to Sales Value (17.22% of Total Sales), Injectables which contributed Rs 82.74 Cr to Sales Value (4.06% of Total Sales), Royalty Income which contributed Rs 19.97 Cr to
Sales Value (0.98% of Total Sales), Export Incentives which contributed Rs 14.77 Cr to Sales Value (0.72% of Total Sales), Other Operating Revenue which contributed Rs 3.30 Cr to Sales Value (0.16% of Total Sales), for the year ending 31-Mar-2015.

For the quarter ended 30-Jun-2015, the company has reported a Standalone sales of Rs. 573.94 Cr., up 16.47% from last quarter Sales of Rs. 492.79 Cr. and up 19.28% from last year same quarter Sales of Rs. 481.17 Cr. Company has reported net profit after tax of Rs. 76.30 Cr. in latest quarter.

The company’s management includes Mr.Chirayu Amin, Mr.K G Ramanathan, Mr.Milin Mehta, Mr.Paresh Saraiya, Mr.Pranav Amin, Mr.Pranav Parikh, Mr.Raj Kumar Baheti, Mr.Shaunak Amin, Dr.Archana Hingorani, Mr.Ajay Desai, Mr.Ajay Desai.

Company has K S Aiyar & Co. as its auditors. As on 30-Sep-2015, the company has a total of 188,515,914 shares outstanding.